# A Framework for the Modulation and Alleviation of Pain Sensations: A Narrative Review

**Authors:** Rushita Dobariya, Niraj Kinariwala, Nirav Parekh, Dhruvi Gangani, Devshree Dave, Hasti Maru, Nandani Mangukiya, Siddhi Singh

PMC · DOI: 10.7759/cureus.83508 · Cureus · 2025-05-05

## TL;DR

This review explores various methods to manage and reduce pain in dentistry, including drugs, therapies, and patient-specific factors for better outcomes.

## Contribution

The paper provides a comprehensive narrative review of multimodal pain management strategies in endodontics, emphasizing recent innovations and biological mechanisms.

## Key findings

- Pharmacological and non-pharmacological methods like cryotherapy and laser therapy show promise in pain reduction.
- GABAergic signaling and interleukin-8 regulation are key in understanding dental pain mechanisms.
- Patient-specific variables significantly influence the effectiveness of pain management strategies.

## Abstract

Modern dentistry and endodontic practice is based on effective pain management, which highlights the necessity of a thorough, multifaceted framework to address both acute and chronic pain. In endodontic applications, this narrative review examines pharmacological, non-pharmacological, and integrative approaches for the regulation and reduction of pain sensations by synthesizing data from a variety of investigations. Apart from pharmaceutical treatments like corticosteroids, clonidine-enhanced local anesthetics, and innovative methods that target peripheral and central pain pathways, significant developments include the use of intracanal cryotherapy, low-level laser therapy (LLLT), and photobiomodulation. To shed light on the biological bases of pain, the roles of GABAergic signaling, interleukin-8 regulation, and neurotransmitters such as substance P are investigated in dental pain mechanisms. Additionally, the review highlights the significance of the intensity of pain prior to surgery, the effectiveness of supplemental treatments such as nano-pulsed lasers, and the importance of patient-specific variables in maximizing pain management. This review includes evidence-based, multimodal solutions to improve patient outcomes and promote a pain-free dental experience by combining state-of-the-art clinical trials, systematic reviews, and meta-analyses.

## Linked entities

- **Chemicals:** clonidine (PubChem CID 2803)

## Full-text entities

- **Genes:** TAC1 (tachykinin precursor 1) [NCBI Gene 6863] {aka Hs.2563, NK2, NKNA, NPK, TAC2}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}
- **Diseases:** Pain (MESH:D010146), acute and chronic pain (MESH:D059787)
- **Chemicals:** clonidine (MESH:D003000)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12135896/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12135896/full.md

## References

70 references — full list in the complete paper: https://tomesphere.com/paper/PMC12135896/full.md

---
Source: https://tomesphere.com/paper/PMC12135896